Clinical Trial Update: uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating uPAR-PET/MRI for assessing tumor aggressiveness in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN